End-to-End Supply Chain Visibility with Axolt ERP Solutions
By integrating advanced features, automation, and real-time analytics, Axolt's cloud ERP gives businesses unmatched control over every link in their supply chain—from raw materials and procurement to final delivery. Let's explore how Axolt is revolutionizing supply chain management through intelligent, connected systems.
Supply chain visibility refers to the ability to track products, components, and data as they move across suppliers, manufacturers, and distributors. It enables businesses to: Monitor inventory in real-time
Predict and respond to disruptions
Optimize procurement and logistics
Enhance supplier collaboration
Improve customer satisfaction
However, achieving this level of transparency is not possible with traditional ERP systems that operate in silos, lack real-time capabilities, and fail to integrate with other platforms.
What sets Axolt apart is its cloud-native architecture and seamless integration with the Salesforce ecosystem. This means businesses benefit from real-time data flow, mobile access, automated workflows, and customizable dashboards—all in one intuitive platform.
With end-to-end functionality across procurement, inventory, production, distribution, and finance, Axolt ERP delivers complete supply chain oversight. Whether you're sourcing raw materials or managing last-mile delivery, Axolt ensures you're equipped with the tools and insights needed to stay agile and competitive.
One of the most critical components of supply chain visibility is inventory management. Axolt offers a robust Inventory module that allows companies to monitor stock levels across multiple locations, warehouses, and channels. This helps prevent costly issues like overstocking, understocking, or inventory obsolescence.
The system uses real-time data and predictive analytics to forecast demand, automate replenishments, and maintain optimal inventory levels. Businesses can set threshold alerts, track expiry dates, and handle batch numbers or serial tracking for precise control.
Axolt ERP automates procurement workflows, enabling faster and more efficient order creation, vendor communication, and approval processes. The platform allows users to: Evaluate supplier performance
Track open purchase orders
Negotiate terms based on real-time inventory data
Generate procurement reports for better decision-making
By maintaining a centralized database of supplier information and integrating it with purchasing and inventory, Axolt enables smarter sourcing strategies and stronger vendor relationships.
For manufacturing businesses, aligning production with supply and demand is vital. Axolt provides integrated production planning tools that connect inventory data with the manufacturing process. Businesses can: Plan work orders based on material availability
Monitor machine and labor utilization
Track production costs in real-time
Adjust schedules to meet customer delivery dates
By unifying production planning with real-time inventory and procurement, Axolt ensures a smoother and more responsive manufacturing process.
Axolt ERP supports seamless order fulfillment and logistics by providing visibility across shipping, warehousing, and distribution. Businesses can: Track shipments in real-time
Automate packing and dispatch
Manage multiple distribution centers
Generate shipping documentation
The platform integrates easily with third-party logistics providers, enabling real-time tracking and status updates across the supply chain. This leads to faster deliveries, fewer errors, and improved customer satisfaction.
What truly sets Axolt ERP apart is its intelligent reporting and analytics. Businesses can customize dashboards, generate performance reports, and leverage predictive insights to: Identify supply chain bottlenecks
Forecast inventory needs
Evaluate vendor performance
Monitor key KPIs such as order cycle time, fill rate, and inventory turnover
These insights empower decision-makers with the data they need to proactively manage operations, reduce costs, and seize new growth opportunities.
Axolt helps retailers manage multi-location inventories, streamline vendor management, and offer omnichannel fulfillment options. With real-time insights into sales and stock movement, retailers can deliver better customer experiences and reduce inventory-related losses.
For manufacturers, Axolt integrates raw material sourcing, production scheduling, and quality control into one platform. Real-time tracking and automation ensure production aligns with demand forecasts and supplier capabilities.
Hospitals and medical providers can manage pharmaceutical inventory, monitor expiration dates, and ensure regulatory compliance. Axolt's inventory tracking ensures that critical medical supplies are available where and when they're needed most.
As global supply chains become more complex and customer expectations continue to rise, the need for transparency, agility, and control has never been more critical. Axolt ERP delivers a future-proof solution that evolves with your business.
By combining Salesforce's trusted infrastructure with advanced ERP capabilities, Axolt empowers businesses to transform their supply chain into a strategic advantage. From inventory and procurement to production and fulfillment, Axolt offers complete end-to-end visibility.
End-to-end supply chain visibility is no longer a luxury—it's a competitive necessity. With Axolt ERP, businesses gain the real-time control, intelligence, and agility needed to thrive in a fast-moving world.
Whether you're a global manufacturer, a growing retailer, or a healthcare provider, Axolt offers the tools to streamline your operations, reduce costs, and deliver better service. Embrace the future of ERP with Axolt and transform your supply chain into a powerhouse of efficiency.
TIME BUSINESS NEWS
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
8 hours ago
- Yahoo
Salesforce (CRM) Price Target Cut to $325 — But Stifel Stays Bullish
Salesforce, Inc. (NYSE:CRM) is one of the Stifel analyst Parker Lane lowered the price target on the stock to $325.00 (from $375.00) while maintaining a Buy rating. The firm believes that Salesforce would have to show improved quarter-over-quarter performance in core and a solid uptick in Data plus AI contributions from the $1 billion level seen last quarter in order to drive multiple appreciation. 'We spoke with four partners following Salesforce's F2Q to get an updated look at business trends. Trends at the agencies were consistent to modestly better Q/Q, driven by minor macro improvements and steady DC/Agentforce traction. Against a tough narrative/sentiment backdrop for the software group (see here), we believe Salesforce will have to show better q/q performance in core and a solid uptick in Data + AI contributions from the $1bn level last quarter to drive multiple appreciation." A financial analyst pouring over graphs and charts related to annuities and fixed index annuities. "We remain believers in the company's long-term positioning and growth opportunity around AI, and look to Dreamforce as an opportunity for management to expand on its vision, provide updates on the pricing/ packaging actions it put in place this year, and offer measures of success for Agentforce following one year in market. We maintain our Buy rating on CRM shares but trim our target price to $325 on multiple compression.' While we acknowledge the potential of CRM as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
16 hours ago
- Yahoo
We're Hopeful That BridgeBio Oncology Therapeutics (NASDAQ:BBOT) Will Use Its Cash Wisely
Explore BridgeBio Oncology Therapeutics's Fair Values from the Community and select yours Just because a business does not make any money, does not mean that the stock will go down. For example, although software-as-a-service business lost money for years while it grew recurring revenue, if you held shares since 2005, you'd have done very well indeed. Nonetheless, only a fool would ignore the risk that a loss making company burns through its cash too quickly. So should BridgeBio Oncology Therapeutics (NASDAQ:BBOT) shareholders be worried about its cash burn? For the purpose of this article, we'll define cash burn as the amount of cash the company is spending each year to fund its growth (also called its negative free cash flow). We'll start by comparing its cash burn with its cash reserves in order to calculate its cash runway. We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free. How Long Is BridgeBio Oncology Therapeutics' Cash Runway? You can calculate a company's cash runway by dividing the amount of cash it has by the rate at which it is spending that cash. As at December 2024, BridgeBio Oncology Therapeutics had cash of US$156m and no debt. In the last year, its cash burn was US$55m. That means it had a cash runway of about 2.8 years as of December 2024. That's decent, giving the company a couple years to develop its business. Depicted below, you can see how its cash holdings have changed over time. View our latest analysis for BridgeBio Oncology Therapeutics How Is BridgeBio Oncology Therapeutics' Cash Burn Changing Over Time? Because BridgeBio Oncology Therapeutics isn't currently generating revenue, we consider it an early-stage business. So while we can't look to sales to understand growth, we can look at how the cash burn is changing to understand how expenditure is trending over time. With the cash burn rate up 4.9% in the last year, it seems that the company is ratcheting up investment in the business over time. That's not necessarily a bad thing, but investors should be mindful of the fact that will shorten the cash runway. Clearly, however, the crucial factor is whether the company will grow its business going forward. For that reason, it makes a lot of sense to take a look at our analyst forecasts for the company. How Hard Would It Be For BridgeBio Oncology Therapeutics To Raise More Cash For Growth? Since its cash burn is increasing (albeit only slightly), BridgeBio Oncology Therapeutics shareholders should still be mindful of the possibility it will require more cash in the future. Issuing new shares, or taking on debt, are the most common ways for a listed company to raise more money for its business. Many companies end up issuing new shares to fund future growth. We can compare a company's cash burn to its market capitalisation to get a sense for how many new shares a company would have to issue to fund one year's operations. BridgeBio Oncology Therapeutics has a market capitalisation of US$921m and burnt through US$55m last year, which is 6.0% of the company's market value. That's a low proportion, so we figure the company would be able to raise more cash to fund growth, with a little dilution, or even to simply borrow some money. Is BridgeBio Oncology Therapeutics' Cash Burn A Worry? As you can probably tell by now, we're not too worried about BridgeBio Oncology Therapeutics' cash burn. In particular, we think its cash runway stands out as evidence that the company is well on top of its spending. Although its increasing cash burn does give us reason for pause, the other metrics we discussed in this article form a positive picture overall. Looking at all the measures in this article, together, we're not worried about its rate of cash burn; the company seems well on top of its medium-term spending needs. On another note, BridgeBio Oncology Therapeutics has 5 warning signs (and 3 which are concerning) we think you should know about. Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of companies with significant insider holdings, and this list of stocks growth stocks (according to analyst forecasts) Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Yahoo
18 hours ago
- Yahoo
Here's Why We're Not At All Concerned With RecycLiCo Battery Materials' (CVE:AMY) Cash Burn Situation
Explore RecycLiCo Battery Materials's Fair Values from the Community and select yours There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although software-as-a-service business lost money for years while it grew recurring revenue, if you held shares since 2005, you'd have done very well indeed. Nonetheless, only a fool would ignore the risk that a loss making company burns through its cash too quickly. Given this risk, we thought we'd take a look at whether RecycLiCo Battery Materials (CVE:AMY) shareholders should be worried about its cash burn. In this report, we will consider the company's annual negative free cash flow, henceforth referring to it as the 'cash burn'. Let's start with an examination of the business' cash, relative to its cash burn. AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. How Long Is RecycLiCo Battery Materials' Cash Runway? A cash runway is defined as the length of time it would take a company to run out of money if it kept spending at its current rate of cash burn. As at April 2025, RecycLiCo Battery Materials had cash of CA$16m and no debt. Looking at the last year, the company burnt through CA$1.4m. That means it had a cash runway of very many years as of April 2025. Even though this is but one measure of the company's cash burn, the thought of such a long cash runway warms our bellies in a comforting way. Depicted below, you can see how its cash holdings have changed over time. View our latest analysis for RecycLiCo Battery Materials How Is RecycLiCo Battery Materials' Cash Burn Changing Over Time? RecycLiCo Battery Materials didn't record any revenue over the last year, indicating that it's an early stage company still developing its business. Nonetheless, we can still examine its cash burn trajectory as part of our assessment of its cash burn situation. Even though it doesn't get us excited, the 48% reduction in cash burn year on year does suggest the company can continue operating for quite some time. Admittedly, we're a bit cautious of RecycLiCo Battery Materials due to its lack of significant operating revenues. We prefer most of the stocks on this list of stocks that analysts expect to grow. How Hard Would It Be For RecycLiCo Battery Materials To Raise More Cash For Growth? Even though it has reduced its cash burn recently, shareholders should still consider how easy it would be for RecycLiCo Battery Materials to raise more cash in the future. Generally speaking, a listed business can raise new cash through issuing shares or taking on debt. Commonly, a business will sell new shares in itself to raise cash and drive growth. We can compare a company's cash burn to its market capitalisation to get a sense for how many new shares a company would have to issue to fund one year's operations. RecycLiCo Battery Materials has a market capitalisation of CA$32m and burnt through CA$1.4m last year, which is 4.4% of the company's market value. Given that is a rather small percentage, it would probably be really easy for the company to fund another year's growth by issuing some new shares to investors, or even by taking out a loan. How Risky Is RecycLiCo Battery Materials' Cash Burn Situation? It may already be apparent to you that we're relatively comfortable with the way RecycLiCo Battery Materials is burning through its cash. For example, we think its cash runway suggests that the company is on a good path. And even its cash burn reduction was very encouraging. After considering a range of factors in this article, we're pretty relaxed about its cash burn, since the company seems to be in a good position to continue to fund its growth. Taking a deeper dive, we've spotted 4 warning signs for RecycLiCo Battery Materials you should be aware of, and 3 of them make us uncomfortable. Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of interesting companies, and this list of stocks growth stocks (according to analyst forecasts) Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
